Fintel reports that on September 5, 2023, Needham reiterated coverage of Cogent Biosciences (NASDAQ:COGT) with a Buy recommendation.Fintel reports that on September 5, 2023, Needham reiterated coverage of Cogent Biosciences (NASDAQ:COGT) with a Buy recommendation.
